Lessin Stuart R
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
J Invest Dermatol. 2006 Nov;126(11):2368-9. doi: 10.1038/sj.jid.5700558.
The impact of immunotherapy on the natural progression of cutaneous T-cell lymphoma (CTCL), particularly the mycosis fungoides and Sézary syndrome variants, has been based on our evolving understanding of the disease's immunobiology.
免疫疗法对皮肤T细胞淋巴瘤(CTCL)自然病程的影响,尤其是蕈样肉芽肿和 Sézary 综合征变体,是基于我们对该疾病免疫生物学不断发展的理解。
J Invest Dermatol. 2006-11
Expert Rev Clin Immunol. 2024-8
J Am Acad Dermatol. 1980-2
Arch Dermatol. 2003-7